VANCOUVER, British Columbia--(BUSINESS WIRE)--CDRD –The Centre for Drug Research and Development, Canada’s national life sciences venture, is pleased to announce the appointment of Mr. Didier Leconte as a new Director of the organization.
Mr. Leconte is Vice-President, Investments - Life Sciences with the Fonds de solidarité FTQ, which he first joined in 2012. With net assets of over $14B, the Fonds de solidarité FTQ has become a hub of knowledge and resources for Québec businesses, and a key player and job creator for the Quebec and Canadian economies.
Over Mr. Leconte’s career, he has held a number of senior leadership positions, all related to advancing innovation. Having started in the energy sector in France, he came to Canada in 1996, first with GDF Suez and then as Commercial Director and later, R&D Director with Gas Technologies Centre. From 2004 to 2012, Mr. Leconte played a significant role in the commercialization of university research in Québec. In 2004, he joined Gestion Univalor, where he was responsible for the innovations portfolio of engineering and sciences, as well as medical devices. He subsequently took on the leadership of MSBi Valorisation, and in 2012, arranged the merger with Valeo Management (now Aligo Innovation), of which he was the interim president.
CDRD Chair, Dr. Brad Popovich commented, “On behalf of the CDRD Board, I am delighted to welcome this exceptional life sciences leader. CDRD is Canada’s life sciences venture, so it is critical to have strong ties and representation from across the country, and certainly with the investors who are leading our industry’s growth. Didier will be a tremendous addition to CDRD as we work to realize our vision of Canadian life sciences leading the world.”
Mr. Gordon C. McCauley, President and CEO of CDRD added, “The CDRD management team is very much looking forward to working closely with Didier. He is at the forefront of life sciences investment in Canada, working with the Fonds de solidarité FTQ on a mission that is perfectly aligned with CDRD’s, to contribute to Québec's and Canada’s economic growth by creating jobs through investments in small and medium-sized businesses, helping them scale up to be new life sciences anchor companies.”
Mr. Leconte holds a degree in materials engineering from Paris XIII University as well as a Masters of Business Administration (MBA), specializing in technology management from UQAM-ESG. He also holds a university certification in Corporate Governance from Université Laval's Collège des administrateurs de sociétés.
About The Centre for Drug Research and Development (CDRD):
CDRD is Canada’s national life sciences venture, powering the country’s life sciences industry by creating and growing companies of scale – while training the scientific and business talent needed to drive them to become leading global anchors for Canada. We do this by building collaborations with the very best partners from academia, industry, patient foundations, the investment community, and other Key Opinion Leaders , and providing the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector — and ultimately into new therapies for patients. www.cdrd.ca.